波多菲洛毒素衍生的天然产品的多目标生物活动
Yuhan Xie1, Shaden A M Khalifa2, Hesham R El-Seedi3
1School of Pharmacy, Macau University of Science and Technology, Macau, 999078, China.
Oncology research
|October 6, 2025
概括
一种天然化合物Podophyllotoxin通过抑制癌细胞和克服药物耐药性,在癌症治疗中表现有前途. 它的修饰形式正在探索,以增强药理特性和免疫调节.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 癌症生物学 癌症生物学
背景情况:
- 波多菲洛毒素是一种天然产品,具有已知的抗癌特性.
- 研究化学修饰以增强其药理作用.
- 了解结构-活性关系是开发新疗法的关键.
研究的目的:
- 为了审查podophyllotoxin的化学修改.
- 概述其抗癌和抗寄生素活动.
- 总结其在克服多药性耐药性和调节免疫反应方面的作用.
主要方法:
- 在C-4和E-4地点检查化学变化.
- 结构与活动关系的分析.
- 关于 podophyllotoxin 的疗效的临床前和临床研究结果的摘要.
主要成果:
- 化学修饰,特别是C-4和E-4的化学修饰,产生了不同的药理学特征.
- 波多菲洛毒素通过双重向 (微管抑制和拓酶II活性) 来克服多药性耐药性.
- 新的机制包括cGAS-STING通路调节,扩大其治疗潜力.
结论:
- 改性波多菲洛毒素衍生物对各种癌症,包括乳腺癌,肺癌和前列腺癌,具有显著的治疗潜力.
- 双重准机制和免疫调节途径为癌症治疗提供了新的途径.
- 为了药物开发,需要进一步研究 podophyllotoxin 的衍生物.
相关概念视频
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K


